| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Bertha K Madra. Psilocybin in Treatment-Resistant Depression. The New England journal of medicine. vol 387. issue 18. 2022-11-02. PMID:36322849. |
psilocybin in treatment-resistant depression. |
2022-11-02 |
2023-08-14 |
Not clear |
| Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, Peter C Arden, Annie Baker, James C Bennett, Catherine Bird, Renske E Blom, Christine Brennan, Donna Brusch, Lisa Burke, Kete Campbell-Coker, Robin Carhart-Harris, Joseph Cattell, Aster Daniel, Charles DeBattista, Boadie W Dunlop, Katherine Eisen, David Feifel, MacKenzie Forbes, Hannah M Haumann, David J Hellerstein, Astrid I Hoppe, Muhammad I Husain, Luke A Jelen, Jeanine Kamphuis, Julie Kawasaki, John R Kelly, Richard E Key, Ronit Kishon, Stephanie Knatz Peck, Gemma Knight, Martijn H B Koolen, Melanie Lean, Rasmus W Licht, Jessica L Maples-Keller, Jan Mars, Lindsey Marwood, Martin C McElhiney, Tammy L Miller, Arvin Mirow, Sunil Mistry, Tanja Mletzko-Crowe, Liam N Modlin, René E Nielsen, Elizabeth M Nielson, Sjoerd R Offerhaus, Veronica O'Keane, Tomáš Páleníček, David Printz, Marleen C Rademaker, Aumer van Reemst, Frederick Reinholdt, Dimitris Repantis, James Rucker, Samuel Rudow, Simon Ruffell, A John Rush, Robert A Schoevers, Mathieu Seynaeve, Samantha Shao, Jair C Soares, Metten Somers, Susan C Stansfield, Diane Sterling, Aaron Strockis, Joyce Tsai, Lucy Visser, Mourad Wahba, Samuel Williams, Allan H Young, Paula Ywema, Sidney Zisook, Ekaterina Malievskai. Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. The New England journal of medicine. vol 387. issue 18. 2022-11-02. PMID:36322843. |
single-dose psilocybin for a treatment-resistant episode of major depression. |
2022-11-02 |
2023-08-14 |
Not clear |
| Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, Peter C Arden, Annie Baker, James C Bennett, Catherine Bird, Renske E Blom, Christine Brennan, Donna Brusch, Lisa Burke, Kete Campbell-Coker, Robin Carhart-Harris, Joseph Cattell, Aster Daniel, Charles DeBattista, Boadie W Dunlop, Katherine Eisen, David Feifel, MacKenzie Forbes, Hannah M Haumann, David J Hellerstein, Astrid I Hoppe, Muhammad I Husain, Luke A Jelen, Jeanine Kamphuis, Julie Kawasaki, John R Kelly, Richard E Key, Ronit Kishon, Stephanie Knatz Peck, Gemma Knight, Martijn H B Koolen, Melanie Lean, Rasmus W Licht, Jessica L Maples-Keller, Jan Mars, Lindsey Marwood, Martin C McElhiney, Tammy L Miller, Arvin Mirow, Sunil Mistry, Tanja Mletzko-Crowe, Liam N Modlin, René E Nielsen, Elizabeth M Nielson, Sjoerd R Offerhaus, Veronica O'Keane, Tomáš Páleníček, David Printz, Marleen C Rademaker, Aumer van Reemst, Frederick Reinholdt, Dimitris Repantis, James Rucker, Samuel Rudow, Simon Ruffell, A John Rush, Robert A Schoevers, Mathieu Seynaeve, Samantha Shao, Jair C Soares, Metten Somers, Susan C Stansfield, Diane Sterling, Aaron Strockis, Joyce Tsai, Lucy Visser, Mourad Wahba, Samuel Williams, Allan H Young, Paula Ywema, Sidney Zisook, Ekaterina Malievskai. Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. The New England journal of medicine. vol 387. issue 18. 2022-11-02. PMID:36322843. |
psilocybin is being studied for use in treatment-resistant depression. |
2022-11-02 |
2023-08-14 |
Not clear |
| Richard Balo. Are Magic Mushrooms Really Magic?: Psilocybin in the Treatment of Depression. Journal of clinical psychopharmacology. 2022-10-17. PMID:36251379. |
: psilocybin in the treatment of depression. |
2022-10-17 |
2023-08-14 |
Not clear |
| Dominika Psiuk, Emilia Magdalena Nowak, Natalia Dycha, Urszula Łopuszańska, Jacek Kurzepa, Marzena Samardakiewic. Esketamine and Psilocybin-The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review. International journal of molecular sciences. vol 23. issue 19. 2022-10-14. PMID:36232748. |
the pubmed/medline database was used to identify articles for systematic review, using the following search terms: (depression) and (psilocybin) or (ketamine). |
2022-10-14 |
2023-08-14 |
Not clear |
| Dominika Psiuk, Emilia Magdalena Nowak, Natalia Dycha, Urszula Łopuszańska, Jacek Kurzepa, Marzena Samardakiewic. Esketamine and Psilocybin-The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review. International journal of molecular sciences. vol 23. issue 19. 2022-10-14. PMID:36232748. |
three articles were devoted to psilocybin in depression treatment and nine to esketamine. |
2022-10-14 |
2023-08-14 |
Not clear |
| Dominika Psiuk, Emilia Magdalena Nowak, Natalia Dycha, Urszula Łopuszańska, Jacek Kurzepa, Marzena Samardakiewic. Esketamine and Psilocybin-The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review. International journal of molecular sciences. vol 23. issue 19. 2022-10-14. PMID:36232748. |
both esketamine and psilocybin demonstrated rapid and long-term effects in reducing depression symptoms and, after overcoming some limitations, may be considered as novel antidepressant agents in future. |
2022-10-14 |
2023-08-14 |
Not clear |
| Ashley Lyon. Self-administration of Psilocybin in the Setting of Treatment-resistant Depression. Innovations in clinical neuroscience. vol 19. issue 7-9. 2022-10-07. PMID:36204170. |
self-administration of psilocybin in the setting of treatment-resistant depression. |
2022-10-07 |
2023-08-14 |
Not clear |
| Tommaso Barba, Sarah Buehler, Hannes Kettner, Caterina Radu, Bruna Giribaldi Cunha, David J Nutt, David Erritzoe, Leor Roseman, Robin Carhart-Harri. Effects of psilocybin versus escitalopram on rumination and thought suppression in depression. BJPsych open. vol 8. issue 5. 2022-09-06. PMID:36065128. |
effects of psilocybin versus escitalopram on rumination and thought suppression in depression. |
2022-09-06 |
2023-08-14 |
Not clear |
| Arny Johannesdottir, Engilbert Sigurdsso. [The use of psilocybin for treatment-resistant depression]. Laeknabladid. vol 108. issue 9. 2022-08-30. PMID:36040772. |
[the use of psilocybin for treatment-resistant depression]. |
2022-08-30 |
2023-08-14 |
human |
| Arny Johannesdottir, Engilbert Sigurdsso. [The use of psilocybin for treatment-resistant depression]. Laeknabladid. vol 108. issue 9. 2022-08-30. PMID:36040772. |
the hallucinogen psilocybin is a potential novel treatment for treatment-resistant depression (trd). |
2022-08-30 |
2023-08-14 |
human |
| Caroline T Golden, Paul Chadderto. Psilocybin reduces low frequency oscillatory power and neuronal phase-locking in the anterior cingulate cortex of awake rodents. Scientific reports. vol 12. issue 1. 2022-07-26. PMID:35882885. |
psilocybin is a hallucinogenic compound that is showing promise in the ability to treat neurological conditions such as depression and post-traumatic stress disorder. |
2022-07-26 |
2023-08-14 |
mouse |
| Thomas D Meyer, Priel Meir, Claudia Lex, Jair C Soare. Magic Mushrooms - an exploratory look at how mental health professionals feel and think about Psilocybin. Psychiatry research. vol 316. 2022-07-25. PMID:35878481. |
psilocybin recently received breakthrough status by the fda for its use in treatment of depression. |
2022-07-25 |
2023-08-14 |
Not clear |
| Oliver G Bosch, Simon Halm, Erich Seifrit. Psychedelics in the treatment of unipolar and bipolar depression. International journal of bipolar disorders. vol 10. issue 1. 2022-07-05. PMID:35788817. |
first randomized, controlled trials with psilocybin show promising efficacy, tolerability, and adherence in the treatment of unipolar depression. |
2022-07-05 |
2023-08-14 |
Not clear |
| Robert Sotille, Herpreet Singh, Anne Weisman, Thomas Vid. Unraveling the Mysteries of Mental Illness With Psilocybin. Cureus. vol 14. issue 5. 2022-06-30. PMID:35769681. |
recent advancements in clinical trials using pure psilocybin in therapy suggest that it may effectively relieve the symptoms of depression in patients diagnosed with major depressive disorder and treatment-resistant depression. |
2022-06-30 |
2023-08-14 |
mouse |
| Robert Sotille, Herpreet Singh, Anne Weisman, Thomas Vid. Unraveling the Mysteries of Mental Illness With Psilocybin. Cureus. vol 14. issue 5. 2022-06-30. PMID:35769681. |
sophisticated cellular and molecular experiments at the systems level have produced evidence that demonstrates psilocybin promotes neuritogenesis in the mouse brain - a mechanism that may address the root cause of depression at the cellular level. |
2022-06-30 |
2023-08-14 |
mouse |
| Gitte M Knudse. Sustained effects of single doses of classical psychedelics in humans. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2022-06-21. PMID:35729252. |
in particular psilocybin, the psychoactive constituent in "magic mushrooms", has shown great potential for treatment of anxiety and depression. |
2022-06-21 |
2023-08-14 |
human |
| Rebecca Smausz, Joanna Neill, John Gig. Neural mechanisms underlying psilocybin's therapeutic potential - the need for preclinical in vivo electrophysiology. Journal of psychopharmacology (Oxford, England). 2022-05-31. PMID:35638159. |
answers to these questions are vital for determining the neural mechanisms mediating psilocybin's psychotherapeutic potential, which promises to improve outcomes for patients with severe depression and other difficulty to treat conditions. |
2022-05-31 |
2023-08-13 |
Not clear |
| Caroline Hayes, Mourad Wahba, Stuart Watso. Will psilocybin lose its magic in the clinical setting? Therapeutic advances in psychopharmacology. vol 12. 2022-04-28. PMID:35480296. |
psilocybin as a novel treatment for depression is garnering a lot of attention from both the mainstream media and the academic community. |
2022-04-28 |
2023-08-13 |
Not clear |
| Roberta Murphy, Hannes Kettner, Rick Zeifman, Bruna Giribaldi, Laura Kartner, Jonny Martell, Tim Read, Ashleigh Murphy-Beiner, Michelle Baker-Jones, David Nutt, David Erritzoe, Rosalind Watts, Robin Carhart-Harri. Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression. Frontiers in pharmacology. vol 12. 2022-04-18. PMID:35431912. |
therapeutic alliance and rapport modulate responses to psilocybin assisted therapy for depression. |
2022-04-18 |
2023-08-13 |
Not clear |